Nob Hill Therapeutics Selected as a Finalist for RESI Innovator’s Pitch Challenge
Nob Hill Therapeutics was selected as a finalist in the Redefining Early Stage Investments (RESI) Innovator’s Pitch Challenge (IPC). An opportunity for early-stage companies to gain exposure to conference attendees,...

